BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021

Dec 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-12-10

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-10	Common Stock	G	700	—	Disposed	303689	Direct
2021-12-15	Common Stock	M	6000	$37.46	Acquired	309689	Direct
2021-12-15	Common Stock	S	6000	$82.71	Disposed	303689	Direct
2021-12-16	Common Stock	M	6000	$37.46	Acquired	309689	Direct
2021-12-16	Common Stock	S	6000	$84.68	Disposed	303689	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-15	Stock Option (Right to buy Common Stock)	$37.46	M	6000	Disposed	2022-05-07	Common Stock (6000)	Direct
2021-12-16	Stock Option (Right to buy Common Stock)	$37.46	M	6000	Disposed	2022-05-07	Common Stock (6000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247533	Indirect

Footnotes

F1: On December 10, 2021 the reporting person gifted 700 shares to an educational institution.

F2: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.